SkinKandy Posts Strong FY26 Growth as Store Network Expands
Source: Kapitales Research
SkinKandy Limited (ASX: SK1) recorded a strong FY26 performance, supported by continued store expansion and healthy customer demand. Pro forma revenue increased 29% to AU$90.2 million, while pro forma NPAT advanced 41% to AU$9.0 million. The company added 22 stores during the year, lifting its network to 109 locations, alongside like-for-like revenue growth of 9.6%. Pro forma EBITDA also rose 41% to AU$24.6 million, benefiting from disciplined cost management and stronger operating efficiency. SkinKandy ended FY26 with AU$13.8 million in cash reserves and no drawn debt, providing financial flexibility for future growth. Momentum remained positive in early FY27, with unaudited revenue rising 22% during the first seven weeks. The company plans to open 18–20 new stores during FY27, excluding international expansion, while advancing preparations to enter another overseas market in the second half of the financial year.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
SkinKandy Posts Strong FY26 Growth as Store Network Expands
SkinKandy ended FY26 with AU$13.8 million in cash reserves and no drawn debt, providing financial flexibility for future growth. Momentum remained positive in early FY27, with unaudited revenue rising 22% during the first seven weeks. The company plans to open 18–20 new stores during FY27, excluding international expansion, while advancing preparations to enter another overseas market in the second half of the financial year.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au